Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1391217
Abstract: ABSTRACT Introduction: Neuroendocrine tumors (NETs) harbor somatostatin receptors and there is a strong rationale for using somatostatin analogs (SSAs) for treatment of NETs. Areas covered: This article discusses i) pharmacology of somatostatin and its analogs;… read more here.
Keywords: somatostatin analogs; treatment neuroendocrine; analogs treatment; neuroendocrine tumors ... See more keywords
Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.
Sign Up to like & getrecommendations! Published in 2020 at "Future oncology"
DOI: 10.2217/fon-2020-0703
Abstract: Neuroendocrine neoplasias (NENs) are a heterogeneous group of rare tumors scattered throughout the body. Surgery, locoregional or ablative therapies as well as maintenance treatments are applied in well-differentiated, low-grade NENs, whereas cytotoxic chemotherapy is usually… read more here.
Keywords: potential predictive; immunotherapy potential; treatment; treatment neuroendocrine ... See more keywords
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.941832
Abstract: Lu-177 has been developed for the treatment of patients with peptide receptor radionuclide therapy (PRRT). A second generation pure no-carrier-added Lu-177 has a high specific activity and has waste disposal advantages over the first generation… read more here.
Keywords: neuroendocrine tumors; added 177; prrt; treatment ... See more keywords
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20123049
Abstract: In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative… read more here.
Keywords: treatment neuroendocrine; treatment; neuroendocrine tumors; somatostatin analogues ... See more keywords